CAMBRIDGE, Britain (AP) — CAMBRIDGE, Britain (AP) — Astrazeneca PLC (AZN) on Thursday reported fourth-quarter earnings of $1.5 billion.
On a per-share basis, the Cambridge, Britain-based company said it had net income of 48 cents. Earnings, adjusted for non-recurring costs, came to $1.05 per share.
The results fell short of Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of $1.07 per share.
The pharmaceutical posted revenue of $14.89 billion in the period, surpassing Street forecasts. Four analysts surveyed by Zacks expected $14.28 billion.
For the year, the company reported profit of $7.04 billion, or $2.25 per share. Revenue was reported as $54.07 billion.
Astrazeneca shares have increased slightly more than 8% since the beginning of the year. The stock has climbed almost 9% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AZN at https://www.zacks.com/ap/AZN
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.